FILE:RTN/RTN-8K-20050812142521.txt.gz
EVENTS:	Regulation FD Disclosure
TEXT:
ITEM: Regulation FD Disclosure
 
 
 
 
 
 
 
 
 
 
 
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
 
 
 
 
ITEM 7.01 REGULATION FD DISCLOSURE
 
In its Form 10-Q for the fiscal period ended June 26, 2005, Raytheon Company (the "Company") stated that it had agreed to make a $50 million equity infusion in Flight Options LLC but that the infusion was objected to by minority equity owners and was the subject of an arbitration. This dispute has been resolved and on August 10, 2005, the Company completed the equity infusion. Flight Options is expected to require further advances or other capital investment in the future.
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Dated: August 12, 2005
 


